{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(1)"],"submitter":["Xiu M"],"funding":["Zhongshan Hospital Special Fund for Specialist Physicians","Specialty Feature Construction Project of Shanghai Pudong New Area Health Commission","Beijing Xisike Clinical Oncolgoy Research Foundation","National Natural Science Foundation of China","Shanghai Sailing Program"],"journal":["Discover oncology"],"pagination":["238"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12872989"],"repository":["biostudies-literature"],"pubmed_title":["LRRC31 is a novel prognostic biomarker and therapeutic target for colorectal cancer."],"pmcid":["PMC12872989"],"funding_grant_id":["Y-HH202102-0001","82160468","PWZzb2022-08","ZP2022-001","23YF1438600"],"pubmed_authors":["Chen J","Xiu M","Wang X","Yu Y"],"additional_accession":[]},"is_claimable":false,"name":"LRRC31 is a novel prognostic biomarker and therapeutic target for colorectal cancer.","description":null,"dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Jan","modification":"2026-07-05T03:18:01.454Z","creation":"2026-07-05T03:11:32.803Z"},"accession":"S-EPMC12872989","cross_references":{"pubmed":["41495324"],"doi":["10.1007/s12672-026-04382-w"]}}